InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: wimuskyfisherman post# 31014

Tuesday, 10/31/2017 6:20:56 AM

Tuesday, October 31, 2017 6:20:56 AM

Post# of 38634
Wimus,
do you seriously believe Rega is dead ?

Sure the recent Pfizer new Lyrica version is not a positive, although they didn't get the OK for fibromyalgia, but why DEAD ?

Doog made an excellent DD on the patents and looks like something is happening both on PODRAS side and Regabatin as well.

What is that "something" is very hard to desume, given the company decision to keep everything in the dark.

One of the few reasons I decided to wait some more as an IPCI investor is Regabatin; PODRAS being the second one and Rexista the other one.
ANDAs became worthless to my investment case, since I believe that just a sudden flow of 3-4 approvals in 3-4 months (=impossible) will cause a share price increase. The IPCI reputation won't change with generics.

IPCI will be playing its future (as a NASDAQ company) in the next 6 months and only a partnership for either Rega, Rexista or Podras could make things good.

JMHO